Wang, R., Guo, T., Wang, Q., Gao, W., Yu, Y., Zhang, J., . . . Zhang, B. (2025). The efficacy and safety of induction chemotherapy combined with sintilimab followed by concurrent chemoradiotherapy plus sintilimab sequencing maintaining with sintilimab for patients with unresectable locally advanced esophageal squamous cell carcinoma. BMC Cancer, 25(1), 1. https://doi.org/10.1186/s12885-025-13457-w
Chicago-referens (17:e uppl.)Wang, Ruifeng, Tianhui Guo, Qi Wang, Wen Gao, Yimiao Yu, Jun Zhang, Wenqian Fu, Haiji Wang, och Biyuan Zhang. "The Efficacy and Safety of Induction Chemotherapy Combined with Sintilimab Followed by Concurrent Chemoradiotherapy Plus Sintilimab Sequencing Maintaining with Sintilimab for Patients with Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma." BMC Cancer 25, no. 1 (2025): 1. https://doi.org/10.1186/s12885-025-13457-w.
MLA-referens (9:e uppl.)Wang, Ruifeng, et al. "The Efficacy and Safety of Induction Chemotherapy Combined with Sintilimab Followed by Concurrent Chemoradiotherapy Plus Sintilimab Sequencing Maintaining with Sintilimab for Patients with Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma." BMC Cancer, vol. 25, no. 1, 2025, p. 1, https://doi.org/10.1186/s12885-025-13457-w.
